Cargando…
Clinical outcomes of combined Preserflo Microshunt implantation and cataract surgery in open-angle glaucoma patients
To assess the effectiveness and safety of the Preserflo Microshunt (PMS) implantation combined with cataract surgery in open-angle glaucoma (OAG) patients. Retrospective, open-label study conducted on insufficiently controlled OAG patients, who underwent a PMS implant procedure with mitomycin-C 0.2%...
Autores principales: | Martínez-de-la-Casa, José M., Saenz-Francés, Federico, Morales-Fernandez, Laura, Perucho, Lucia, Mendez, Carmen, Fernandez-Vidal, Ana, Garcia-Saenz, Sofía, Sanchez-Jean, Ruben, García-Feijoo, Julian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329158/ https://www.ncbi.nlm.nih.gov/pubmed/34341454 http://dx.doi.org/10.1038/s41598-021-95217-x |
Ejemplares similares
-
Preliminary results of Preserflo Microshunt versus Preserflo Microshunt and Ologen implantation
por: Vastardis, Iraklis, et al.
Publicado: (2021) -
PreserFlo™ MicroShunt Combined with Phacoemulsification versus PreserFlo™ MicroShunt as a Standalone Procedure in Patients with Medically Resistant Open-Angle Glaucoma
por: Fili, Sofia, et al.
Publicado: (2022) -
Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma
por: Ibarz Barberá, Marta, et al.
Publicado: (2022) -
PreserFlo(®) MicroShunt: An Overview of This Minimally Invasive Device for Open-Angle Glaucoma
por: Gambini, Gloria, et al.
Publicado: (2022) -
Evaluation of a Novel Αb Εxterno MicroShunt for the Treatment of Glaucoma
por: Burgos-Blasco, Barbara, et al.
Publicado: (2022)